We therefore investigated SDF-1, the ligand for the GPCR CXCR4, which has been associated with poor prognosis and malignancy of melanoma [35]; but again, it was not measurably attractive to cells in our assays (Figure 4B, compare with strong response to serum). The gene discussed is CXCR4; the disease is melanoma.